Get Full Government Meeting Transcripts, Videos, & Alerts Forever!
Get email alerts on the Enforcement Compounding topic
No spam. Unsubscribe anytime.
Enforcement committee advances approach for AB 1902 accessibility rules, updates self‑assessment drafts and approves consolidated petition form
Summary
The Enforcement and Compounding Committee recommended a policy approach to implement AB 1902’s prescription label accessibility requirements, advanced updates to self‑assessment drafts and proposed a consolidated petition form.
Get email alerts on the Enforcement Compounding topic
No spam. Unsubscribe anytime.
The Enforcement and Compounding Committee reported to the full California Board of Pharmacy on committee work that covered implementation planning for Assembly Bill 1902 on prescription label accessibility, recommended changes to several self‑assessment forms and presented a consolidated petition form for board approval.
AB 1902 implementation: Committee chair Maria Serpa told the board that the committee prefers regulations focused on requiring pharmacies to develop policies and procedures describing how the pharmacy will meet each patient’s needs for an accessible prescription label. The committee emphasized pharmacy flexibility because the method to meet a patient’s needs may vary by individual (for example, large‑print labels, Braille, electronic formats or other accommodations). The committee said it intends to consider draft regulations at a future meeting if the board concurs with that policy direction.
Self‑assessment updates and posting drafts: The committee reviewed and recommended targeted changes to the community pharmacy self‑assessment (several sections highlighted in the meeting materials), hospital outpatient pharmacy self‑assessment and hospital pharmacy self‑assessment (including removal of a provision relating to veterinary prescriptions). The committee instructed staff to incorporate previously received public comments where appropriate (including suggestions from Kaiser Permanente on hospital form drafting) and recommended the board approve posting updated drafts on the board’s website so regulated entities would have more current guidance while comprehensive revisions continue.
Public comments during the item included a brief statement from John Gray, a registered pharmacist with Kaiser Permanente, thanking board staff for considering Kaiser’s comments on the hospital self‑assessment and urging the board to carry specific suggested edits into the consolidated draft. Another commenter, Julie Threet of Chico, made extended remarks during the public comment period that were unrelated to the committee’s agenda items; those remarks are recorded in the public comment section of the transcript and were not addressed by the committee.
Petition form consolidation: The committee recommended, and the board approved, a consolidated petition form to be used for requests for reinstatement of license, modification of penalty and early termination of probation. Committee members said the consolidated form should make it easier for petitioners and ensure consistent information is provided to the board.
Enforcement statistics: The committee provided enforcement statistics for the first eight months of fiscal year 2024–25: 2,099 complaints initiated, 1,971 investigations closed, and 1,495 field investigations pending as of March 1, 2025. The meeting materials included a breakdown of average time frames for stages of investigation.
Why it matters: AB 1902 will require accessible prescription labeling; the committee’s policy preference for a procedures‑based regulation seeks to give pharmacies options to meet patient needs rather than endorsing a single technical solution. Updating self‑assessment forms and consolidating petition forms affect how pharmacies document compliance and how licensees seek board relief.
Ending
The board voted to accept the committee recommendations, post interim drafts, and approved the consolidated petition form; staff will continue drafting regulation text for AB 1902 implementation and will return to the committee and full board with future proposals.

